Intensity Therapeutics In... (INTS)

NASDAQ: INTS · Real-Time Price · USD

0.60

-0.04 (-5.79%)

At close: Apr 29, 2025, 3:59 PM

0.60

-0.05%

After-hours: Apr 29, 2025, 07:50 PM EDT

Intensity Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	2.59M	2.78M	3.24M	7.46M	8.56M	6.69M	135.76K	616.51K	1.31M	696.57K	1.72M	3.04M	4.54M	7.41M	8.11M	9.32M
Short-Term Investments	n/a	n/a	3.08M	3.04M	6.22M	8.96M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50K	50K
Other Long-Term Assets	1.3M	1.3M	1.1M	1.1M	1.68M	28.44K	167.74K	167.74K	167.74K	167.74K	167.74K	181.54K	167.74K	49.59K	182.1K	-18.3K
Receivables	n/a	n/a	n/a	n/a	n/a	14.37K	17.84M	72.41K	62.3K	56.43K	67.9K	63.53K	51.26K	47.22K	60.13K	67.81K
Inventory	n/a	n/a	n/a	n/a	n/a	956.87K	n/a	38.64K	29.36K	n/a	60.37K	150.61K	70.44K	171.82K	1.00	217.17K
Other Current Assets	n/a	n/a	1.12M	n/a	6K	n/a	5.58K	17.58K	46.8K	73.63K	26.61K	13.63K	69.28K	70.66K	7.67K	176.88K
Total Current Assets	3.36M	3.79M	7.44M	11.17M	15.46M	16.63M	18.06M	745.14K	1.45M	852.82K	1.88M	3.27M	4.73M	7.7M	8.26M	9.63M
Property-Plant & Equipment	122K	128K	135K	141K	147K	152.6K	n/a	38.62K	139.09K	184.52K	229.5K	274.03K	318.13K	361.79K	447.84K	490.24K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.42M	1.43M	1.23M	1.24M	1.83M	181.04K	167.74K	206.35K	306.83K	352.26K	397.24K	455.57K	485.86K	411.37K	679.93K	521.94K
Total Assets	4.78M	5.21M	8.67M	12.41M	17.3M	16.82M	18.23M	951.49K	1.76M	1.21M	2.27M	3.72M	5.22M	8.11M	8.94M	10.15M
Account Payables	1.22M	540K	1.92M	1.22M	3.05M	358.4K	1.58M	899.44K	603K	796.3K	463.34K	539.89K	172.51K	295.1K	205.16K	222.71K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	27K	n/a	20K	10.56K	n/a	4.48M	4.35M	2.25M	2.05M	2.03M	2.02M	2M	173.96K	n/a
Other Current Liabilities	56K	1.75M	812K	n/a	479K	-10.56K	n/a	n/a	-655	2.06M	n/a	n/a	n/a	n/a	849.3K	n/a
Total Current Liabilities	1.75M	2.32M	3.2M	2.52M	3.96M	723.97K	3.06M	6.88M	6.82M	5.38M	4.67M	4.37M	3.72M	4.42M	1.51M	1.35M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	36K	36K	36K	36K	10.04M	10.04M	36K	10.04M	10.04M	10.04M	10.04M	36K	10.04M
Total Long-Term Liabilities	110K	117K	124K	167K	174K	180.89K	36K	10.04M	10.04M	36K	10.08M	10.13M	10.18M	10.23M	317.6K	10.36M
Total Liabilities	1.86M	2.43M	3.33M	2.69M	4.13M	904.86K	3.09M	16.91M	16.85M	5.42M	14.75M	14.5M	13.9M	14.65M	1.83M	11.71M
Total Debt	138K	145K	151K	157K	158K	155.45K	n/a	4.52M	4.49M	2.25M	2.28M	2.31M	2.34M	2.37M	455.56K	497.48K
Common Stock	2K	1K	1K	1K	1K	1.37K	1.31K	341.00	341.00	682.00	682.00	682.00	682.00	682.00	682.00	682.00
Retained Earnings	-66.78M	-63.6M	-60.09M	-55.12M	-50.52M	-47.34M	-45.01M	-39.99M	-38.65M	-37.14M	-35.37M	-33.44M	-31.07M	-28.67M	-24.65M	-23.18M
Comprehensive Income	n/a	n/a	n/a	n/a	-17.3M	-16.82M	-78.31B	n/a	n/a	-682	n/a	n/a	-31.07M	n/a	-682	-23.18M
Shareholders Equity	2.92M	2.78M	5.34M	9.72M	13.16M	15.91M	15.13M	-15.96M	-15.1M	-4.21M	-12.48M	-10.78M	-8.68M	-6.54M	7.12M	-1.56M
Total Investments	n/a	n/a	3.08M	3.04M	6.22M	8.96M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50K	50K